CORT Q4 2020 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86M-2.5% YoY

Gross Profit

$84M98.5% margin

Operating Income

$31M35.6% margin

Net Income

$26M30.3% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

-0.7%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

$35M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$572M

Total Liabilities

$48M

Stockholders' Equity

$523M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$88M	-2.5%
Gross Profit	$84M	$86M	-2.3%
Operating Income	$31M	$35M	-12.9%
Net Income	$26M	$29M	-11.5%